| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
| 09/01/1999 | EP0938547A1 Modified ligands of calcium-dependent binding proteins |
| 09/01/1999 | EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938489A1 New phosphonates, process for preparing the same and medicaments |
| 09/01/1999 | EP0938487A2 2$i(R),4$i(S),$i(R),$i(S)- AND 2$i(S),4$i(R),$i(R),$i(S)-HYDROXYITRACONAZOLE- AND HYDROXYSAPERCONAZOLE DERIVATIVES |
| 09/01/1999 | EP0938486A1 Substituted pyrrolopyrimidines and processes for their preparation |
| 09/01/1999 | EP0938485A1 Benzoxazole derivative with an affinity to binding sites of amino acid receptors |
| 09/01/1999 | EP0938484A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole |
| 09/01/1999 | EP0938483A2 Muscarinic antagonists |
| 09/01/1999 | EP0938482A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor |
| 09/01/1999 | EP0938480A1 Substituted tetrahydro-1,3,5-triazin-2 1h]-thiones as anti-atherosclerotic agents |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938476A1 Process for substituted pyridines |
| 09/01/1999 | EP0938475A1 Piperidine compounds |
| 09/01/1999 | EP0938474A2 Cyclopropylindole compounds and their use as prodrugs |
| 09/01/1999 | EP0938472A2 15-fluoro prostaglandins as ocular hypotensives |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938345A1 Aqueous-based pharmaceutical composition |
| 09/01/1999 | EP0938343A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 09/01/1999 | EP0938339A1 Formulations for topical use |
| 09/01/1999 | EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof |
| 09/01/1999 | EP0938327A1 Method of inhibiting the release of bioactive il-1 |
| 09/01/1999 | EP0938326A1 Synthetic phosphopeptides for treating bone diseases |
| 09/01/1999 | EP0938325A1 Methods for sterilizing male mammals |
| 09/01/1999 | EP0938323A2 Treatment of highly vascular tumours |
| 09/01/1999 | EP0938322A2 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
| 09/01/1999 | EP0938321A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv |
| 09/01/1999 | EP0938320A1 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/01/1999 | EP0938319A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying |
| 09/01/1999 | EP0938318A1 Tablet with controlled release of alfuzosine chlorydrate |
| 09/01/1999 | EP0938317A1 Compositions and methods for reducing respiratory depression |
| 09/01/1999 | EP0938316A2 Galenic composition containing opioid antagonists |
| 09/01/1999 | EP0938315A1 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 09/01/1999 | EP0938314A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (r)-trihexyphenidyl |
| 09/01/1999 | EP0938313A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-clidinium |
| 09/01/1999 | EP0938312A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia |
| 09/01/1999 | EP0938311A2 Use of efaroxan for producing medicine for treating huntington disease |
| 09/01/1999 | EP0938310A1 Anti-viral compounds |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938308A1 Antiparasitic agents |
| 09/01/1999 | EP0938306A1 ANTIMALARIAL COMPOSITIONS CONTAINING $i(CIS)-FUSED CYCLOPENTENO-1,2,4-TRIOXANE DERIVATIVES |
| 09/01/1999 | EP0938305A2 Method of alleviating pain by means of combining tramadol with an nmda antagonist |
| 09/01/1999 | EP0938304A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
| 09/01/1999 | EP0938303A1 Antioxidant-induced apoptosis in vascular smooth muscle cells |
| 09/01/1999 | EP0938302A1 Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 09/01/1999 | EP0938297A1 Immunomodulatory formulation |
| 09/01/1999 | EP0938296A1 Method of treating alopecia |
| 09/01/1999 | EP0938258A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no) |
| 09/01/1999 | EP0886645B1 New 19-nor-pregnene derivatives |
| 09/01/1999 | EP0835254B1 Oxazolidinone derivatives, their preparation and therapeutical use |
| 09/01/1999 | EP0828497B1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 09/01/1999 | EP0808111B1 A low phosphorus animal feed containing 1 -alpha- hydroxylated vitamin d compounds |
| 09/01/1999 | EP0764174B1 Process for removing bile salts from a patient and alkylated compositions therefor |
| 09/01/1999 | EP0721348B1 Monoglyceride/lactate ester permeation enhancer |
| 09/01/1999 | EP0691842B1 Lidocaine aerosol anaesthetic |
| 09/01/1999 | EP0687267B1 Pyrrolo-pyridine derivatives as ligands of dopamine receptor |
| 09/01/1999 | EP0650475B1 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides, their preparation and their use as 5-ht2 antagonists |
| 09/01/1999 | EP0643780B2 Multiple solvent cleaning system |
| 09/01/1999 | EP0622078B1 Cholesterol level depressant |
| 09/01/1999 | EP0573545B1 Monoclonal antibodies against receptor-induced binding sites |
| 09/01/1999 | CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections |
| 09/01/1999 | CN1227602A Tumor antigen proteins, genes thereof and tumor antigen peptides |
| 09/01/1999 | CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus |
| 09/01/1999 | CN1227564A Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 09/01/1999 | CN1227563A Modified oligosaccharides |
| 09/01/1999 | CN1227560A Thienopyrimidines |
| 09/01/1999 | CN1227559A Highly lipophilic camptothecin derivatives |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227553A Bicyclic pyrimidine derivatives and their use as anti-coagulants |
| 09/01/1999 | CN1227552A Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 09/01/1999 | CN1227550A Troponyl piperazines as selective dopamine D4 receptor ligands |
| 09/01/1999 | CN1227547A Arylalkanoyl pyridazines |
| 09/01/1999 | CN1227544A Tetrahydroquinoline derivatives as EAA antagonists |
| 09/01/1999 | CN1227543A Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 09/01/1999 | CN1227542A N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 09/01/1999 | CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 09/01/1999 | CN1227538A Pharmaceutical composition containing 4-oxo-butynic acid |
| 09/01/1999 | CN1227503A Novel device for transdermal administering of trimegestone |
| 09/01/1999 | CN1227495A Compositions of plant carbohydrates as dietary supplements |
| 09/01/1999 | CN1227493A The use of heparin or heparan sulfate in combination with chitosan for prevention or treatment of infections caused by herpes virus |
| 09/01/1999 | CN1227492A Transdermal systems containing two active principles in separate compartments, their method of preparation and application as medicine |
| 09/01/1999 | CN1227491A Method for treating sinusitis with uridine triphosphates and related compounds |
| 09/01/1999 | CN1227490A Fat emulsion containing xanthine derivative |
| 09/01/1999 | CN1227489A Adenosine deaminase inhibitors |
| 09/01/1999 | CN1227488A Improved method for preparing potassim clavulanate |
| 09/01/1999 | CN1227487A Pharmaceutical compositions containing mesembrine and related compounds |
| 09/01/1999 | CN1227486A Pharmaceutical compositions comprising S-(-)-N-propargyl-1-amino indan |
| 09/01/1999 | CN1227485A Treatment of hemoglobinopathy |
| 09/01/1999 | CN1227483A Anti-caries oral compositions |
| 09/01/1999 | CN1227482A Cosmetic compositions |
| 09/01/1999 | CN1227466A Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 09/01/1999 | CN1227227A Antisense nucleoside for inhibiting the growth of human malignant tumor |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 09/01/1999 | CN1227101A Medicine synergist |
| 09/01/1999 | CN1227100A Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method |
| 09/01/1999 | CN1227099A Novel treatment agent |
| 09/01/1999 | CN1044912C Thio-substituted cyclic phosphonate compounds, and its pharmaceutical compositions and use |
| 09/01/1999 | CN1044911C Method for preparing prodrug |